UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

00091 EFFECT OF INTRAPERITONEAL HYPERTHERMIC CHEMOTHERAPY USING PACLITAXEL, CARBOPLATIN ON ADVANCED OVARIAN CANCER

International journal of gynecological cancer, 2005-09, Vol.15 (Suppl 2), p.76-77

2005

Volltextzugriff (PDF)

0704: Epithelioid Trophoblastic Tumor of Paracervix and Parametrium

International journal of gynecological cancer, 2006-10, Vol.16 (Suppl 3), p.798-798

2006

Volltextzugriff (PDF)

1-(2-Nitrophenyl)thiosemicarbazides: a novel class of potent, orally active non-peptide antagonist for the bradykinin B(2) receptor

Journal of medicinal chemistry, 2000-03, Vol.43 (5), p.769

2000

Volltextzugriff (PDF)

1-(2-Nitrophenyl)thiosemicarbazides: A Novel Class of Potent, Orally Active Non-Peptide Antagonist for the Bradykinin B 2 Receptor

Journal of medicinal chemistry, 2000-03, Vol.43 (5), p.769-771

2000

Volltextzugriff (PDF)

1-(2-Nitrophenyl)thiosemicarbazides: A Novel Class of Potent, Orally Active Non-Peptide Antagonist for the Bradykinin B2 Receptor

Journal of medicinal chemistry, 2000-03, Vol.43 (5), p.769-771

2000

Volltextzugriff (PDF)

IL-1β induces MMP-9 via reactive oxygen species and NF-κB in murine macrophage RAW 264.7 cells

Biochemical and biophysical research communications, 2002-10, Vol.298 (2), p.251-256

2002

Volltextzugriff (PDF)

A 10nm platform technology for low power and high performance application featuring FINFET devices with multi workfunction gate stack on bulk and SOI

2014 Symposium on VLSI Technology (VLSI-Technology): Digest of Technical Papers, 2014, p.1-2

2014

Volltextzugriff (PDF)

IL-11 is a crucial determinant of cardiovascular fibrosis

Nature (London), 2017-12, Vol.552 (7683), p.110-115

2017

Volltextzugriff (PDF)

1238PTRY - A PHASE II STUDY TO EVALUATE SAFETY AND EFFICACY OF COMBINED TRASTUZUMAB AND THE HSP90 INHIBITOR AUY922 IN ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC) WITH HER2 OVEREXPRESSION OR AMPLIFICATION OR MUTATION

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv433-iv433

2014

Volltextzugriff (PDF)

140. Implementing cryopreservation of garlic germplasm collections using the droplet-vitrification technique

Cryobiology, 2007-12, Vol.55 (3), p.371-371

2007

Volltextzugriff (PDF)

145COMBINED GLUCOSE AND FRUCTOSE SUPPLEMENTATION IN PROTEIN-FREE KSOM IMPROVES PREIMPLANTATION DEVELOPMENT OF BOVINE TRANSGENIC CLONED EMBRYOS

Reproduction fertility and development, 2004, Vol.16 (2), p.194

2004

Volltextzugriff (PDF)

185 NONSURGICAL EMBRYO TRANSFER FOR PRODUCTION OF PIGS BY IN VITRO FERTILIZATION AND SOMATIC CELL NUCLEAR TRANSFER

Reproduction fertility and development, 2010, Vol.22 (1), p.251

2010

Volltextzugriff (PDF)

193 DIFFERENTIAL EFFECTS OF CULTURE ON APOPTOTIC GENE EXPRESSION IN THE PRE-IMPLANTATION CLONED EMBRYOS OF MINIATURE PIG

Reproduction fertility and development, 2007, Vol.19 (1), p.213

2007

Volltextzugriff (PDF)

1ppm Device to Chip Level Reliability Characterization for High-Density DDR5 DRAMs

2023 International Electron Devices Meeting (IEDM), 2023, p.1-4

2023

Volltextzugriff (PDF)

2,2′,4,6,6′-Pentachlorobiphenyl-Induced Apoptosis Is Limited by Cyclooxygenase-2 Induction

Toxicological sciences, 2005-02, Vol.83 (2), p.397-404

2005

Volltextzugriff (PDF)

2-Nitrophenylcarbamoyl-( S )-prolyl-( S )-3-(2-naphthyl)alanyl- N -benzyl- N - methylamide (SDZ NKT 343), a Potent Human NK 1 Tachykinin Receptor Antagonist with Good Oral Analgesic Activity in Chronic Pain Models

Journal of medicinal chemistry, 1998-08, Vol.41 (17), p.3159-3173

1998

Volltextzugriff (PDF)

2-Nitrophenylcarbamoyl-(S)-prolyl-(S)-3-(2-naphthyl)alanyl-N-benzyl-N- methylamide (SDZ NKT 343), a Potent Human NK1 Tachykinin Receptor Antagonist with Good Oral Analgesic Activity in Chronic Pain Models

Journal of medicinal chemistry, 1998-08, Vol.41 (17), p.3159-3173

1998

Volltextzugriff (PDF)

2-Nitrophenylcarbamoyl-(S)-prolyl-(S)-3-(2-naphthyl)alanyl-N-benzylide (SDZ NKT 343), a potent human NK1 tachykinin receptor antagonist with good oral analgesic activity in chronic pain models

Journal of medicinal chemistry, 1998, Vol.41 (17), p.3159-3173

1998

Volltextzugriff (PDF)

20 GHz integrated CMOS frequency sources with a quadrature VCO using transformers

2004 IEE Radio Frequency Integrated Circuits (RFIC) Systems. Digest of Papers, 2004, p.269-272

2004

Volltextzugriff (PDF)

2022 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Support; Education, Implementation, and Teams; and First Aid Task Forces

Circulation (New York, N.Y.), 2022-12, Vol.146 (25), p.e483-e557

2022

Volltextzugriff (PDF)

2219

Ultrasound in medicine & biology, 2006-05, Vol.32 (5), p.P132

2006

Volltextzugriff (PDF)

2219: Breast lesions with discordant results at ultrasound-guided core needle biopsy

Ultrasound in medicine & biology, 2006, Vol.32 (5), p.P132-P132

2006

Volltextzugriff (PDF)

23-P-18 - Vapor phase Beckmann rearrangement of cyclohexanone oxime over tantalum pillared magadiite

Studies in Surface Science and Catalysis, 2001, Vol.135, p.234-234

2001

Volltextzugriff (PDF)

264PDGAIN2: ADJUVANT PHASE III TRIAL COMPARING AN INTENSIFIED DOSE-DENSE ADJUVANT THERAPY WITH ENPC COMPARED WITH A DOSE-DENSE, DOSE-ADAPTED THERAPY WITH DTEC DTDOCETAXEL IN PATIENTS WITH PRIMARY BREAST CANCER AND A HIGH RISK OF RECURRENCE

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv90-iv90

2014

Volltextzugriff (PDF)

1 – 25 von 3.631

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.045)
Mit Volltextzugriff
(3.062)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(2.431)
Life Sciences & Biomedicine
(1.342)
Humans
(975)
Physical Sciences
(746)
Biological And Medical Sciences
(627)
Male
(621)
Female
(595)
Technology
(594)
Physics
(588)
Medical Sciences
(504)
Adult
(410)
Middle Aged
(404)
Animals
(382)
Aged
(301)
Exact Sciences And Technology
(287)
Engineering
(234)
Materials Science
(223)
Biochemistry & Molecular Biology
(173)
Fundamental And Applied Biological Sciences. Psychology
(168)
Mice
(167)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Ingenta
(1.378)
EZB Electronic Journals Library
(1.311)
MEDLINE
(1.309)
Standalone journals
(918)
Journals@Ovid Complete
(845)
ScienceDirect
(773)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(608)
American Physical Society Journals
(444)
IngentaConnect Journals
(419)
PROLA
(399)
Wiley-Blackwell Journals
(384)
Springer journals
(306)
Wiley Online Library Full Collection 2018
(275)
IEEE Electronic Library (IEL)
(194)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(171)
Oxford Journals
(139)
Oxford Journals 2020 Medicine
(108)
Nature Journals
(108)
Taylor & Francis Journals
(96)
American Institute of Physics
(86)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

00091 EFFECT OF INTRAPERITONEAL HYPERTHERMIC CHEMOTHERAPY USING PACLITAXEL, CARBOPLATIN ON ADVANCED OVARIAN CANCER

0704: Epithelioid Trophoblastic Tumor of Paracervix and Parametrium

1-(2-Nitrophenyl)thiosemicarbazides: a novel class of potent, orally active non-peptide antagonist for the bradykinin B(2) receptor

1-(2-Nitrophenyl)thiosemicarbazides: A Novel Class of Potent, Orally Active Non-Peptide Antagonist for the Bradykinin B 2 Receptor

1-(2-Nitrophenyl)thiosemicarbazides: A Novel Class of Potent, Orally Active Non-Peptide Antagonist for the Bradykinin B2 Receptor

IL-1β induces MMP-9 via reactive oxygen species and NF-κB in murine macrophage RAW 264.7 cells

A 10nm platform technology for low power and high performance application featuring FINFET devices with multi workfunction gate stack on bulk and SOI

IL-11 is a crucial determinant of cardiovascular fibrosis

1238PTRY - A PHASE II STUDY TO EVALUATE SAFETY AND EFFICACY OF COMBINED TRASTUZUMAB AND THE HSP90 INHIBITOR AUY922 IN ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC) WITH HER2 OVEREXPRESSION OR AMPLIFICATION OR MUTATION

140. Implementing cryopreservation of garlic germplasm collections using the droplet-vitrification technique

145COMBINED GLUCOSE AND FRUCTOSE SUPPLEMENTATION IN PROTEIN-FREE KSOM IMPROVES PREIMPLANTATION DEVELOPMENT OF BOVINE TRANSGENIC CLONED EMBRYOS

185 NONSURGICAL EMBRYO TRANSFER FOR PRODUCTION OF PIGS BY IN VITRO FERTILIZATION AND SOMATIC CELL NUCLEAR TRANSFER

193 DIFFERENTIAL EFFECTS OF CULTURE ON APOPTOTIC GENE EXPRESSION IN THE PRE-IMPLANTATION CLONED EMBRYOS OF MINIATURE PIG

1ppm Device to Chip Level Reliability Characterization for High-Density DDR5 DRAMs

2,2′,4,6,6′-Pentachlorobiphenyl-Induced Apoptosis Is Limited by Cyclooxygenase-2 Induction

2-Nitrophenylcarbamoyl-( S )-prolyl-( S )-3-(2-naphthyl)alanyl- N -benzyl- N - methylamide (SDZ NKT 343), a Potent Human NK 1 Tachykinin Receptor Antagonist with Good Oral Analgesic Activity in Chronic Pain Models

2-Nitrophenylcarbamoyl-(S)-prolyl-(S)-3-(2-naphthyl)alanyl-N-benzyl-N- methylamide (SDZ NKT 343), a Potent Human NK1 Tachykinin Receptor Antagonist with Good Oral Analgesic Activity in Chronic Pain Models

2-Nitrophenylcarbamoyl-(S)-prolyl-(S)-3-(2-naphthyl)alanyl-N-benzylide (SDZ NKT 343), a potent human NK1 tachykinin receptor antagonist with good oral analgesic activity in chronic pain models

20 GHz integrated CMOS frequency sources with a quadrature VCO using transformers

2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage: A Guideline From the American Heart Association/American Stroke Association

2219

2219: Breast lesions with discordant results at ultrasound-guided core needle biopsy

23-P-18 - Vapor phase Beckmann rearrangement of cyclohexanone oxime over tantalum pillared magadiite

264PDGAIN2: ADJUVANT PHASE III TRIAL COMPARING AN INTENSIFIED DOSE-DENSE ADJUVANT THERAPY WITH ENPC COMPARED WITH A DOSE-DENSE, DOSE-ADAPTED THERAPY WITH DTEC DTDOCETAXEL IN PATIENTS WITH PRIMARY BREAST CANCER AND A HIGH RISK OF RECURRENCE

Suchergebnisse filtern